z-logo
open-access-imgOpen Access
The Anti-Cancer Effect of A3 Adenosine Receptor Agonists: A Novel, Targeted Therapy
Author(s) -
Pnina Fishman,
Kenneth A. Jacobson,
Avivit Ochaion,
Shira Cohen,
S. BarYehuda
Publication year - 2007
Publication title -
immunology endocrine and metabolic agents - medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 17
eISSN - 1875-6115
pISSN - 1871-5222
DOI - 10.2174/187152207781369878
Subject(s) - cancer research , wnt signaling pathway , cyclin d1 , protein kinase b , adenosine receptor , receptor , adenosine , signal transduction , pharmacology , melanoma , in vivo , cancer , chemistry , biology , agonist , medicine , endocrinology , biochemistry , cell cycle , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom